The Bengaluru-based company has built three CRISPR platforms covering molecular diagnostics, gene editing and disease modelling, and is commercialising the diagnostics one first.
A patient who picks up an infection in hospital needs the right antibiotic quickly.
Working out which drugs the infection still responds to can take days by standard culture testing.
Clinicians prescribe broadly while they wait, and that broad prescribing is one of the ways drug resistance spreads.
India records high rates of drug-resistant infections.
was founded in 2020 to apply CRISPR, the gene editing technology, to this very problem and others like it.
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed…
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high…
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high…
The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that orchestrates the…
Karnataka launches a statewide antimicrobial resistance surveillance program with TIGS to track resistance trends and inform…
Bengaluru startup Mandrake Bio secured sixteen crore rupees in new funding. This capital will expand their AI and biophysics…
